Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
183 | 3 | NOONAN SYNDROME//PTEN//CELL BIOLOGY | 56293 |
1016 | 2 | PTEN//MTOR//PI3K | 10616 |
1321 | 1 | MTOR//RAPAMYCIN//MTORC2 | 2732 |
2970 | 1 | PTEN//COWDEN SYNDROME//LHERMITTE DUCLOS DISEASE | 2127 |
4527 | 1 | PIK3CA//PI3K INHIBITOR//PI3K | 1801 |
6660 | 1 | PDK1//AKT//AKT2 | 1487 |
7306 | 1 | PI3K GAMMA//LYMPHOCYTE SIGNALLING DEV//PI3K DELTA | 1408 |
16537 | 1 | S6K2//RIBOSOMAL S6 KINASE 2 S6K2//P70 S6 KINASE | 676 |
29252 | 1 | SESTRIN 2//SESTRIN//ANTICANC MOL ONCOL | 208 |
35540 | 1 | REDD1//RTP801//DDIT4 | 111 |
38283 | 1 | OXIDATIVE BALANCE SCORE//AFFLIATED NANJING CHILDRENS HOSP//AKT1 SNP RS2498804 | 66 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PTEN | authKW | 853740 | 8% | 33% | 885 |
2 | MTOR | authKW | 449890 | 7% | 19% | 780 |
3 | PI3K | authKW | 279013 | 5% | 19% | 484 |
4 | COWDEN SYNDROME | authKW | 251012 | 1% | 70% | 121 |
5 | PIK3CA | authKW | 226207 | 2% | 40% | 190 |
6 | AKT | authKW | 224707 | 7% | 10% | 761 |
7 | LHERMITTE DUCLOS DISEASE | authKW | 202171 | 1% | 89% | 77 |
8 | RAPAMYCIN | authKW | 173186 | 4% | 15% | 391 |
9 | COWDEN DISEASE | authKW | 162531 | 1% | 77% | 71 |
10 | PI3K INHIBITOR | authKW | 153044 | 1% | 61% | 85 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 36047 | 31% | 0% | 3312 |
2 | Cell Biology | 22209 | 25% | 0% | 2601 |
3 | Biochemistry & Molecular Biology | 14432 | 33% | 0% | 3475 |
4 | Chemistry, Medicinal | 1977 | 5% | 0% | 508 |
5 | Genetics & Heredity | 1404 | 6% | 0% | 657 |
6 | Pathology | 862 | 3% | 0% | 339 |
7 | Biophysics | 726 | 4% | 0% | 435 |
8 | Hematology | 543 | 3% | 0% | 319 |
9 | Medicine, Research & Experimental | 462 | 4% | 0% | 395 |
10 | Pharmacology & Pharmacy | 245 | 6% | 0% | 596 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CLIN CANC GENET PROGRAM | 35786 | 0% | 29% | 42 |
2 | HUMAN CANC GENET GRP | 27834 | 0% | 28% | 34 |
3 | STANLEY SHALOM ZIELONY NURSING EXCELLENCE | 26756 | 0% | 48% | 19 |
4 | LYMPHOCYTE SIGNALLING DEV | 26024 | 0% | 23% | 39 |
5 | ANTICANC MOL ONCOL | 23927 | 0% | 73% | 11 |
6 | GERMLINE HIGH RISK FOCUS GRP | 20768 | 0% | 100% | 7 |
7 | INOSITIDE SIGNALLING GRP | 18535 | 0% | 63% | 10 |
8 | GRP PHOSPHOSITES | 16307 | 0% | 50% | 11 |
9 | HIGH THROUGHPUT SCREENING MOL PHARMACOL | 16150 | 0% | 78% | 7 |
10 | STANLEY SHALOM ZIELONY NURSING | 15256 | 0% | 86% | 6 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOLECULAR CANCER THERAPEUTICS | 8359 | 1% | 3% | 110 |
2 | ONCOGENE | 8137 | 2% | 1% | 230 |
3 | JOURNAL OF BIOLOGICAL CHEMISTRY | 6517 | 6% | 0% | 617 |
4 | CLINICAL CANCER RESEARCH | 6195 | 2% | 1% | 183 |
5 | CELLULAR SIGNALLING | 5541 | 1% | 2% | 93 |
6 | CANCER RESEARCH | 5467 | 3% | 1% | 280 |
7 | ONCOTARGET | 5218 | 2% | 1% | 174 |
8 | SCIENCE SIGNALING | 3666 | 0% | 3% | 45 |
9 | MOLECULAR AND CELLULAR BIOLOGY | 3545 | 2% | 1% | 170 |
10 | CURRENT CANCER DRUG TARGETS | 2783 | 0% | 3% | 31 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PTEN | 853740 | 8% | 33% | 885 | Search PTEN | Search PTEN |
2 | MTOR | 449890 | 7% | 19% | 780 | Search MTOR | Search MTOR |
3 | PI3K | 279013 | 5% | 19% | 484 | Search PI3K | Search PI3K |
4 | COWDEN SYNDROME | 251012 | 1% | 70% | 121 | Search COWDEN+SYNDROME | Search COWDEN+SYNDROME |
5 | PIK3CA | 226207 | 2% | 40% | 190 | Search PIK3CA | Search PIK3CA |
6 | AKT | 224707 | 7% | 10% | 761 | Search AKT | Search AKT |
7 | LHERMITTE DUCLOS DISEASE | 202171 | 1% | 89% | 77 | Search LHERMITTE+DUCLOS+DISEASE | Search LHERMITTE+DUCLOS+DISEASE |
8 | RAPAMYCIN | 173186 | 4% | 15% | 391 | Search RAPAMYCIN | Search RAPAMYCIN |
9 | COWDEN DISEASE | 162531 | 1% | 77% | 71 | Search COWDEN+DISEASE | Search COWDEN+DISEASE |
10 | PI3K INHIBITOR | 153044 | 1% | 61% | 85 | Search PI3K+INHIBITOR | Search PI3K+INHIBITOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |
rank | cluster_id2 | link |
---|---|---|
1 | 2386 | ANGIOMYOLIPOMA//TUBEROUS SCLEROSIS//TUBEROUS SCLEROSIS COMPLEX |
2 | 3102 | FOXM1//FOXO1//FOXO3A |
3 | 2363 | PEUTZ JEGHERS SYNDROME//AMPK//LKB1 |
4 | 1446 | EIF4E//TRANSLATION INITIATION//IRES |
5 | 1147 | AUTOPHAGY//BECLIN 1//LC3 |
6 | 3936 | PIM KINASE//TCTP//PIM 1 |
7 | 1014 | INSULIN RECEPTOR//GLUT4//GLYCOSYLPHOSPHATIDYLINOSITOL |
8 | 3522 | ALKYLPHOSPHOCHOLINES//HEXADECYLPHOSPHOCHOLINE//EDELFOSINE |
9 | 1440 | VDAC//WARBURG EFFECT//LONIDAMINE |
10 | 1549 | RAS//FARNESYLTRANSFERASE//RAL |